The Senior Director, Business Development Transactionssupportsthe execution of complex partnering, licensing, collaboration and acquisition deals that shape CSL’s future portfolio and scientific leadership. This role translatesTAinsights, enterprise strategy and cross-functional perspectives into high-quality transaction structures and negotiation outcomes. It serves as a senior deal strategist, ensuring CSL secures partnerships that deliver scientific, commercial, and financial value while managing enterprise risk with discipline.
RESPONSIBILITIES AND ACCOUNTABILITIES
List the essential job duties and responsibilities in order of priority or time spent on each. Include only those items that are the sole or primary reason the job exists, items that require specialized skills or training, and items that demanda significant portionof time to perform (Do not list competencies, education, training requirements, etc.).
Transaction Execution Leadership
1. Leadexecution of CSL’s high-priority licensing agreements, research collaborations, asset acquisitions, equity-linkeddealsand divestitures
2. TranslateTA evaluationassumptions, due diligence findings and strategic intent into precise negotiation strategies, dealtermsand execution plans
Deal Structuring & Negotiation Strategy
3. Shape deal structures, financial constructs and key contractual terms that balance scientific opportunity with commercial viability and risk tolerance
4. Partner closely withBD TA,Legal/IPandFinance to define defensible positions, valuation baselines, negotiationboundariesand fallback strategies
5. Working closely with BD TA, represent CSL as a senior negotiator in external partner discussions, ensuring alignment with enterprise priorities and long-term alliance success
Diligence Leadership
6. Lead cross-functional diligence programs covering scientific, clinical, regulatory, commercial, CMC, supply, legal and operational domains
7. Ensure diligence findings directly inform deal shaping, risk mitigation and integration planning.
8. Drive clarity and transparency of risks,assumptionsand trade-offs for governance stakeholders.
Governance & Decision Support
9. Prepare high-quality PRISM and senior leadership decision materials that clearly articulate deal rationale, valuation considerations,risksand strategic impact.
10. Ensure all transactions adhere to CSL governance standards, compliancerequirementsand industry best practices.
11. Facilitatetimelydecision-making by surfacing issues early and driving alignment across functions.
Enterprise Orchestration & Cross-Functional Partnership
12. Align stakeholders across R&D, Commercial, Technical Operations,CorporateStrategy, Finance and Enterprise Alliance Management.
13. Drive enterprise judgementby ensuring rigorous debate, transparenttrade-offsand alignment to long-range strategy.
14. Collaborate with BDTAto ensure transaction structures reflect scientific and commercial assumptions.
Post-Signature Handover & Early-Life Support
15. Ensure smooth transition of executed deals to Alliance Management and operational owners, including risk registers,obligationsand communications.
16. Provide early-life issue resolution support during theinitialstabilisationperiod of partnerships and alliances.
Team Leadership & Capability Building
17. Mentor and guidemore junior members of the team, strengthening CSL’s internal dealmaking capability.
18. Contribute to developing tools, templates, negotiationframeworksand knowledge repositories that elevate the function.
19. Drivea culture of discipline, strategic thinking, and deal quality across the BD Transactions team.
About CSL Behring
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.
CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries.
To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit and CSL Plasma at .
Our Benefits